EFFECT OF FOOD ON PHARMACOKINETICS AND SAFETY OF DA-8010, A NOVEL SELECTIVE MUSCARINIC RECEPTOR ANTAGONIST, IN HEALTHY SUBJECTS

被引：0
|
作者：
Khwarg, J. [1 ]
Yang, E. [1 ]
Chung, W. [1 ]
Park, S. [1 ]
Jang, I [1 ]
Cho, J. [1 ]
Ryu, C. [2 ]
Lee, D. [2 ]
Lee, M. [2 ]
Kim, H. [3 ]
Lee, S. [1 ]
机构：
[1] Seoul Natl Univ, Dept Clin Pharmacol & Therapeut, Coll Med & Hosp, Seoul, South Korea
[2] Dong A ST Res Inst, Yongin, South Korea
[3] Dong A ST Co Ltd, Seoul, South Korea
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2022年 / 78卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
31
引用
收藏
页码：S29 / S30
页数：2
相关论文
共 50 条
  • [21] Psychomotor effects, pharmacokinetics and safety of the orexin receptor antagonist suvorexant administered in combination with alcohol in healthy subjects
    Sun, Hong
    Yee, Ka Lai
    Gill, Sean
    Liu, Wen
    Li, Xiaodong
    Panebianco, Deborah
    Mangin, Eric
    Morrison, Dennis
    McCrea, Jacqueline
    Wagner, John A.
    Troyer, Matthew D.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2015, 29 (11) : 1159 - 1169
  • [22] Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects
    Morcos, Peter N.
    Guerini, Elena
    Parrott, Neil
    Dall, Georgina
    Blotner, Steven
    Bogman, Katrijn
    Sturm, Carolina
    Balas, Bogdana
    Martin-Facklam, Meret
    Phipps, Alex
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2017, 6 (04): : 388 - 397
  • [23] Food effect trial of the pharmacokinetics and safety of TQ05105 in healthy Chinese subjects
    Dai, Jun
    Cheng, Yang
    Zhou, Yannan
    Wang, Yanli
    Liu, Zhengzhi
    Ren, Qing
    Su, Zhengjie
    Deng, Qiaohuan
    Yang, Haimiao
    Cui, Yingzi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 95 (01)
  • [24] PHARMACOKINETICS (PK) OF HZN-825, A SMALL MOLECULE SELECTIVE ANTAGONIST OF LPAR1, AND THE EFFECT OF FOOD IN HEALTHY ADULT SUBJECTS
    Song, Y.
    Ali, F.
    Ye, Z.
    Zarzoso, J.
    Rogowski, J.
    Sun, Y.
    Xin, Y.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S66 - S67
  • [25] SAFETY, TOLERANCE, AND PHARMACOKINETICS OF XANOMELINE TARTRATE, A NOVEL MUSCARINIC M1 AGONIST IN HEALTHY ELDERLY SUBJECTS
    SATTERWHITE, JH
    LUCAS, RA
    HEATON, J
    CARTER, GV
    NEUROBIOLOGY OF AGING, 1994, 15 : S104 - S104
  • [26] Effect of food on the pharmacokinetics of fiduxosin in healthy male subjects
    Dutta, S
    Zhang, YM
    Granneman, GR
    Verlinden, M
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2002, 27 (01) : 49 - 52
  • [27] Effect of food intake on the pharmacokinetics of rivoceranib in healthy subjects
    Sachar, Madhav
    Park, Cheol Hee
    Pesco-Koplowitz, Luana
    Koplowitz, Barry
    McGinn, Arlo
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 (01) : 171 - 181
  • [28] Effect of food on the pharmacokinetics of fiduxosin in healthy male subjects
    Sandeep Dutta
    Yiming Zhang
    G. Richard Granneman
    Marleen Verlinden
    European Journal of Drug Metabolism and Pharmacokinetics, 2002, 27 : 49 - 52
  • [29] Pharmacokinetics and pharmacodynamics of the ETA-selective endothelin receptor antagonist SPP301 in healthy human subjects
    Dietarle, W
    Mann, J
    Kutz, K
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (01): : 59 - 66
  • [30] Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P1 Receptor Modulator in Healthy Subjects
    Juif, Pierre-Eric
    Baldoni, Daniela
    Reyes, Maribel
    Wilbraham, Darren
    Febbraro, Salvatore
    Vaclavkova, Andrea
    Hoch, Matthias
    Dingemanse, Jasper
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (12)
12345